P1.01-54 A Phase I/Ib Study of Binimetinib (MEK162), a MEK Inhibitor Plus Carboplatin/Pemetrexed in Non-Squamous NSCLC
Graham, D., Chen, E., Pisters, K., Bradbury, P., Trinkaus, M., Chan, M., Arif, S., Zurawska, U., Rothenstein, J., Zawisza, D., Effendie, S., Sawczak, M., Leighl, N.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article